Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Albuterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 9/20 | 0.87 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.87 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.87 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.87 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.87 |
| ▸ | TSHR | P16473 | 1/20 | 0.87 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.87 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | CASP1 | P29466 | 1/20 | 0.60 |
| ▸ | CASP7 | P55210 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Albuterol SCHEMBL33280 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Albuterol SCHEMBL29372778 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Albuterol SCHEMBL33279 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Levosalbutamol SCHEMBL29568212 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Albuterol SCHEMBL6861017 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Levosalbutamol SCHEMBL33281 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Albuterol SCHEMBL2405201 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Albuterol SCHEMBL2556890 | 1.00 | PMP22 (1.00) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Albuterol SCHEMBL15995296 | 0.99 | PMP22 (0.97) | PMP22ADRB2HIF1AADRB1CYP1A2 | |
| Albuterol SCHEMBL5472402 | 0.99 | PMP22 (0.97) | PMP22ADRB2HIF1AADRB1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140330587-A1 | MEDICAL DIAGNOSIS DERIVED FROM PATIENT DRUG HISTORY DATA | 3M INNOVATIVE PROPERTIES COMPANY | 2014-11-06 | — | — | US | disclosed |
| US-8814790-B2 | Medical diagnosis derived from patient drug history data | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-08-26 | — | — | US | disclosed |
| US-8579811-B2 | Medical diagnosis derived from patient drug history data | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-11-12 | — | — | US | disclosed |
| US-20130226618-A1 | MEDICAL DIAGNOSIS DERIVED FROM PATIENT DRUG HISTORY DATA | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| EP-2148663-A2 | PULMONARY DELIVERY OF SPHERICAL INSULIN MICROPARTICLES | Baxter International Inc. (US) | 2010-02-03 | — | — | EP | disclosed |
| EP-2034883-A2 | MEDICAL DIAGNOSIS DERIVED FROM PATIENT DRUG HISTORY DATA | 3M Innovative Properties Company (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008130803-A2 | PULMONARY DELIVERY OF SPHERICAL INSULIN MICROPARTICLES | BAXTER INTERNATIONAL INC. (US) | 2008-10-30 | — | — | WO | disclosed |
| EP-1944016-A1 | Propellant-based microparticle formulatons | BAXTER INTERNATIONAL INC. (US) | 2008-07-16 | — | — | EP | disclosed |
| EP-1418890-B1 | PROPELLANT-BASED MICROPARTICLE FORMULATIONS | BAXTER INT (US) | 2008-05-14 | — | — | EP | disclosed |
| US-20080081955-A1 | MEDICAL DIAGNOSIS DERIVED FROM PATIENT DRUG HISTORY DATA | 3M INNOVATIVE PROPERTIES COMPANY | 2008-04-03 | — | — | US | disclosed |
| US-20080026068-A1 | PULMONARY DELIVERY OF SPHERICAL INSULIN MICROPARTICLES | BAXTER HEALTHCARE S.A. (CH) | 2008-01-31 | — | — | US | disclosed |
| WO-2007149675-A2 | MEDICAL DIAGNOSIS DERIVED FROM PATIENT DRUG HISTORY DATA | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-12-27 | — | — | WO | disclosed |
| EP-1418890-A1 | PROPELLANT-BASED MICROPARTICLE FORMULATIONS | BAXTER INTERNATIONAL INC. (US) | 2004-05-19 | — | — | EP | disclosed |
| US-20030064033-A1 | Propellant-based microparticle formulations | BAXTER HEALTHCARE SA (A CORPORATION OF SWITZERLAND) (CH) | 2003-04-03 | — | — | US | disclosed |
| WO-2003015750-A1 | PROPELLANT-BASED MICROPARTICLE FORMULATIONS | BAXTER INTERNATIONAL, INC. (US) | 2003-02-27 | — | — | WO | disclosed |